BARCELONA — Intravenous patient-controlled administration of hydromorphone offers better pain control and higher patient satisfaction compared with conventional oral morphine in managing severe cancer pain, according to new research presented here at the European Society for Medical Oncology (ESMO) Congress. The US National Comprehensive Cancer Network (NCCN) guidelines recommend maintaining analgesia for persistent cancer pain …
